推薦產品
生物源
mouse
品質等級
共軛
unconjugated
抗體表格
purified antibody
抗體產品種類
primary antibodies
無性繁殖
MH9A3, monoclonal
分子量
calculated mol wt 15.91 kDa
純化經由
using protein G
物種活性
human
包裝
antibody small pack of 100 μL
技術
ELISA: suitable
flow cytometry: suitable
multiplexing: suitable
neutralization: suitable
同型
IgG1
表位序列
Unknown
Protein ID登錄號
UniProt登錄號
運輸包裝
dry ice
目標翻譯後修改
unmodified
基因資訊
mouse ... il9> IL9(3578)
一般說明
Interleukin-9 (UniProt: P15248; also known as IL-9, Cytokine P40, T-cell growth factor P40) is encoded by the IL9 gene (Gene ID: 3578) in human. IL-9 is a pleiotropic cytokine that plays a significant role in tolerance and inflammation. It is expressed by a variety of immune cells. It is synthesized with a signal peptide (aa 1-18), which is subsequently cleaved off to generate the mature form. It supports the growth of mast cells, T cells, and several other cell types, including erythroid progenitors, fetal thymocytes, human megakaryoblastic leukemic cells, and myeloid precursor cells. It is also reported to supports IL-2 independent and IL-4 independent growth of helper T-cells. It also plays a role in promoting IgE production by B cells. IL-9 actions are mediated via its binding to IL-9R that results in the formation the IL-9R heterocomplex. Following its binding to the IL-9R , the SHC is phosphorylated, which then binds to Grb2 that subsequently activates SoS, a GTP exchange factor for Ras GTPases. This results in the activation of Ras GTPase that activates Raf kinase followed by the activation of MEK1/2 and ERK1/2. Although IL-9 is reported to activate the MAPK pathway in several lymphoid and hematopoietic cells, this activation is weaker compared to other cytokines. Elevated levels of IL-9 and IL-9R are observed in lungs of asthmatic subjects. (Ref.: Chakraborty, S., et al. (2019). Int. J. Mol. Sci. 20(9); 2113).
特異性
Clone MH9A3 is a mouse monoclonal antibody that detects human Interleukin-9.
免疫原
Ovalbumin-conjugated recombinant human Interleukin-9.
應用
Quality Control Testing
Evaluated by ELISA with recombinant human IL-9.
ELISA Analysis: Various dilution of this antibody detected recombinant human Interleukin-9 (IL-9).
Tested Applications
ELISA Analysis: A representative lot detected IL-9 in ELISA applications (Jenmalm, M.C., et al. (2001). Clin Exp Allergy.;31(10):1528-35; Faulkner, H., et al. (2002). J Infect Dis.;185(5):665-72; Bottcher, M.F., et al. (2003). Pediatr Allergy Immunol.;14(5):345-50; Holz, L.E., et al. (2005). J Inflamm (Lond).;2:3.; Stephens, G.L., et al. (2011). Eur J Immunol.;41(4):952-62; Muls, N., et al. (2012). J Neuroimmunol.;243(1-2):73-80; Peters, C., et al. (2018). Oncoimmunology.;8(1):e1522471).
Flow Cytometry Analysis: A representative lot detected IL-9 in Flow Cytometry applications (Stephens, G.L., et al. (2011). Eur J Immunol.;41(4):952-62; Peters, C., et al. (2018). Oncoimmunology.;8(1):e1522471).
Multiplexing: A representative lot detected IL-9 in Multiplexing applications (Peters, C., et al. (2018). Oncoimmunology.;8(1):e1522471).
Neutralizing: A representative lot neutralized the action of IL-9 in Neutralizing applications (Stephens, G.L., et al. (2011). Eur J Immunol.;41(4):952-62).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Evaluated by ELISA with recombinant human IL-9.
ELISA Analysis: Various dilution of this antibody detected recombinant human Interleukin-9 (IL-9).
Tested Applications
ELISA Analysis: A representative lot detected IL-9 in ELISA applications (Jenmalm, M.C., et al. (2001). Clin Exp Allergy.;31(10):1528-35; Faulkner, H., et al. (2002). J Infect Dis.;185(5):665-72; Bottcher, M.F., et al. (2003). Pediatr Allergy Immunol.;14(5):345-50; Holz, L.E., et al. (2005). J Inflamm (Lond).;2:3.; Stephens, G.L., et al. (2011). Eur J Immunol.;41(4):952-62; Muls, N., et al. (2012). J Neuroimmunol.;243(1-2):73-80; Peters, C., et al. (2018). Oncoimmunology.;8(1):e1522471).
Flow Cytometry Analysis: A representative lot detected IL-9 in Flow Cytometry applications (Stephens, G.L., et al. (2011). Eur J Immunol.;41(4):952-62; Peters, C., et al. (2018). Oncoimmunology.;8(1):e1522471).
Multiplexing: A representative lot detected IL-9 in Multiplexing applications (Peters, C., et al. (2018). Oncoimmunology.;8(1):e1522471).
Neutralizing: A representative lot neutralized the action of IL-9 in Neutralizing applications (Stephens, G.L., et al. (2011). Eur J Immunol.;41(4):952-62).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Anti-IL-9, clone MH9A3, Cat. No. MABF2786, is a mouse monoclonal antibody that detects Interleukin-9 and is tested for use in ELISA, Flow Cytometry, Multiplexing, and Neutralizing.
外觀
Purified mouse monoclonal antibody IgG1 in buffer containing PBS without preservatives.
儲存和穩定性
Store at -10°C to -25°C. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
其他說明
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
免責聲明
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到適合的產品?
試用我們的產品選擇工具.
儲存類別代碼
12 - Non Combustible Liquids
水污染物質分類(WGK)
WGK 1
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務